BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9792359)

  • 1. AVERT: a user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention interventions on HIV transmission.
    Rehle TM; Saidel TJ; Hassig SE; Bouey PD; Gaillard EM; Sokal DC
    AIDS; 1998; 12 Suppl 2():S27-35. PubMed ID: 9792359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting sexually transmissible infection prevention trials by adjusting for the magnitude of exposure.
    Wilson DP
    Clin Trials; 2010 Feb; 7(1):36-43. PubMed ID: 20007407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexually transmitted disease and HIV prevalence and risk factors in concentrated and generalized HIV epidemic settings.
    NIMH Collaborative HIV/STD Prevention Trial Group
    AIDS; 2007 Apr; 21 Suppl 2():S81-90. PubMed ID: 17413267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring effectiveness in community randomized trials of HIV prevention.
    Hallett TB; Garnett GP; Mupamberiyi Z; Gregson S
    Int J Epidemiol; 2008 Feb; 37(1):77-87. PubMed ID: 18096590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.
    Korenromp EL; White RG; Orroth KK; Bakker R; Kamali A; Serwadda D; Gray RH; Grosskurth H; Habbema JD; Hayes RJ
    J Infect Dis; 2005 Feb; 191 Suppl 1():S168-78. PubMed ID: 15627227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania.
    Hayes RJ; Changalucha J; Ross DA; Gavyole A; Todd J; Obasi AI; Plummer ML; Wight D; Mabey DC; Grosskurth H
    Contemp Clin Trials; 2005 Aug; 26(4):430-42. PubMed ID: 15951245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Safer Choices" intervention: its impact on the sexual behaviors of different subgroups of high school students.
    Kirby DB; Baumler E; Coyle KK; Basen-Engquist K; Parcel GS; Harrist R; Banspach SW
    J Adolesc Health; 2004 Dec; 35(6):442-52. PubMed ID: 15581523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of STD control: an operational model.
    Rao P; Mohamedali FY; Temmerman M; Fransen L
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S17-22. PubMed ID: 10023348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent human immunodeficiency virus and sexually transmitted disease prevention programmes: are gender-blind approaches justified?
    Ateka GK; Selwyn BJ
    Public Health; 2007 Sep; 121(9):682-9. PubMed ID: 17543358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data.
    Rajan SS; Sokal D
    J Epidemiol Community Health; 2011 Feb; 65(2):111-5. PubMed ID: 20558420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of treatment for sexually transmitted disease on HIV transmission.
    Browne R; Nwokolo N; Boag F
    J HIV Ther; 2003 Aug; 8(3):67-71. PubMed ID: 12951544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
    Dowdy DW; Sweat MD; Holtgrave DR
    AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a behavioral intervention for seropositive youth.
    Lee MB; Leibowitz A; Rotheram-Borus MJ
    AIDS Educ Prev; 2005 Apr; 17(2):105-18. PubMed ID: 15899749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of HIV prevention and the epidemiological context.
    Grassly NC; Garnett GP; Schwartländer B; Gregson S; Anderson RM
    Bull World Health Organ; 2001; 79(12):1121-32. PubMed ID: 11799444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral interventions--rationale, measurement, and effectiveness.
    Zenilman JM
    Infect Dis Clin North Am; 2005 Jun; 19(2):541-62. PubMed ID: 15963887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workers.
    Vickerman P; Ndowa F; O'Farrell N; Steen R; Alary M; Delany-Moretlwe S
    Sex Transm Infect; 2010 Jun; 86(3):163-8. PubMed ID: 19854700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collecting sexually transmitted disease clinic chart data in multisite studies. NIMH Multisite HIV Prevention Trial.
    AIDS; 1997 Dec; 11 Suppl 2():S59-63. PubMed ID: 9475713
    [No Abstract]   [Full Text] [Related]  

  • 18. Complementary hypothesis concerning the community sexually transmitted disease mass treatment puzzle in Rakai, Uganda.
    Boily MC; Lowndes CM; Alary M
    AIDS; 2000 Nov; 14(16):2583-92. PubMed ID: 11101071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural interventions to prevent HIV/sexually transmitted disease: are they cost-effective for women in the southern United States?
    Cohen DA; Wu SY; Farley TA
    Sex Transm Dis; 2006 Jul; 33(7 Suppl):S46-9. PubMed ID: 16794555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling cost-effectiveness of HIV prevention programs.
    Johnson-Masotti AP
    Expert Rev Pharmacoecon Outcomes Res; 2003 Aug; 3(4):409-25. PubMed ID: 19807451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.